The future of bypassing agents for hemophilia with inhibitors in the era of novel agents-Reference-Cited by-同舟云学术

The future of bypassing agents for hemophilia with inhibitors in the era of novel agents

Published:2018-10-11 Issue:12 Volume:16 Page:2362-2374
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Shapiro A. D.¹,Mitchell I. S.²^ORCID,Nasr S.²

Affiliation:

1. Indiana Hemophilia and Thrombosis Center, Inc.; Indianapolis IN USA

2. GLOVAL, LLC; Broomfield CO USA

Funder

HEMA Biologics

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.14296/fullpdf

Reference89 articles.

1. Use of prothrombin complex concentrates (PCC) in hemophiliacs with inhibitors: Lack of correlation between clinical response and laboratory parameters;Buchanan;Pediatr Res,1977

2. Inhibitors in hemophilia patients: current status and management;Aledort;Am J Hematol,1994

3. PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding;Wang;Haemophilia,2017

4. Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH;Chitlur;J Thromb Haemost,2014

5. Evaluating and monitoring the efficacy of recombinant activated factor VIIa in patients with haemophilia and inhibitors;Qi;Blood Coagul Fibrinolysis,2014

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AAV mediated genome engineering with a bypass coagulation factor alleviates the bleeding phenotype in a murine model of hemophilia B;Thrombosis Research;2024-06

2. Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial;Blood;2024-05-30

3. Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single‐arm, open‐label study;Haemophilia;2024-02-05

4. Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective;Haemophilia;2024-02-05

5. Emicizumab prophylaxis in people with hemophilia A and inhibitors: a systematic review and meta-analysis;Sao Paulo Medical Journal;2024